Introduction/Overview
Natural products, as an important source of drug discovery, play an irreplaceable role in the long history of human fight against diseases. In the treasure trove of traditional Chinese medicine, Huanglian（Coptis chinensis Franch. is famous for its significant effects of clearing heat, drying dampness, purging fire, and detoxifying. Its main active ingredient, berberine alkaloids, has always been a hot topic in natural product chemistry and pharmacology research. Among the numerous alkaloids of Coptis chinensis, berberine has been extensively studied, and Coptis alkaloids and their derivatives, which have similar structures, have gradually shown unique pharmacological value in recent years, attracting widespread attention from the academic community.
Coptis sulfate, as a sulfate form of isoquinoline alkaloids isolated from Coptis chinensis, is endowed with unique biological properties due to its chemical nature. Early research mainly focused on its broad-spectrum antibacterial activity, which is highly consistent with the traditional application of Huanglian. However, as research deepens, a new role of berberine sulfate in the field of immune regulation has been revealed: it has been found to be an effective, non competitive inhibitor of indoleamine 2,3-dioxygenase (IDO). IDO is a key rate limiting enzyme in the tryptophan kynurenine metabolic pathway, playing a central role in tumor immune evasion, chronic infections, and autoimmune diseases. The inhibitory activity of berberine sulfate on IDO (Ki value of 5.8 μ M, IC50 value of 6.3 μ M) has elevated it from a traditional antibacterial natural product to a potential lead compound with immunotherapeutic value.
This article aims to provide a systematic professional review of berberine sulfate. We will trace its plant origin and extraction methods based on its chemical structure and physicochemical properties, explore its pharmacological activities in antibacterial and immune regulation, and analyze its interaction mechanism with molecular targets such as IDO. On this basis, combined with the drug parameters and pharmacokinetic characteristics, evaluate its potential and challenges as a drug lead compound, and look forward to its clinical application prospects in the fields of antibacterial and tumor immunotherapy. Through this review, we hope to provide a comprehensive and in-depth academic reference on berberine sulfate for natural product researchers, medicinal chemists, and pharmacologists.
Chemical structure and physicochemical properties
The chemical structure of berberine sulfate belongs to the original berberine alkaloids, and its parent nucleus is a tetracyclic isoquinoline skeleton. Compared with berberine, the structural characteristics of berberine are the methylenedioxy rings at C-2 and C-3 positions, as well as the methoxy groups at C-9 and C-10 positions. In berberine sulfate, the cation of berberine and the anion of sulfate form a salt through ionic bonding. Its molecular formula is C ₁₉ H ₁₄ NO ₄⁺ · HSO ₄⁻, with a molecular weight of 320.3240 (calculated as coptisine cation, the actual salt has a higher molecular weight).
From the perspective of physical and chemical properties, berberine sulfate exhibits typical quaternary ammonium alkaloid characteristics. Its LogP value is -0.1756, indicating that the compound has low fat solubility and strong hydrophilicity. This characteristic is closely related to the positively charged quaternary ammonium nitrogen atom in its molecule. Although its water solubility (0.1706 mg/mL) is not high, as a sulfate salt, its solubility is usually better than its free base form. The topological polar surface area (TPSA) of polarity is 40.8000 Å ², which is relatively small and suggests that it has some potential for cell membrane penetration, although its quaternary ammonium structure may limit its passive diffusion.
It is worth noting that the blood-brain barrier (BBB) penetration of berberine sulfate was evaluated as "high". This is a relatively rare characteristic for a quaternary ammonium alkaloid, as most quaternary ammonium compounds are difficult to pass through the blood-brain barrier due to their high polarity. This characteristic may be related to its small molecular weight, low TPSA, and possible active transport mechanism. The high BBB penetration provides potential for its application in central nervous system diseases such as neuroinflammation and brain tumors. In addition, a negative evaluation of hERG inhibition indicates a lower risk in terms of cardiac safety, which is an important pharmacological advantage. The Ames test result is 2.4, indicating that it may have potential genetic toxicity, which needs to be given special attention and validation in subsequent drug development.
Plant sources and extraction methods
The main plant source of berberine sulfate is the Ranunculaceae genus in the Ranunculaceae family（Coptis）The roots and stems of plants. Among them, the most commonly used medicinal plants include Huanglian（C. chinensis）Sanjiaoye Huanglian（C. deltoidea）He Yunlian（C. teeta）. These plants are widely distributed and cultivated in China, Japan, and Southeast Asia. In addition, in Huangteng（Fibraurea recisa）Huanglian alkaloids have also been found in other plants.
The content of alkaloids in Huanglian varies depending on the variety, origin, harvesting season, and processing method. Usually, the total alkaloid content in the rhizome of Coptis chinensis can reach more than 10%, with berberine having the highest content (about 5-8%), while the content of berberine is relatively low, about 0.5-2%. Therefore, efficient extraction and purification of berberine sulfate from Huanglian require refined processes.
The traditional extraction method is mainly based on the acid-base properties of alkaloids. The general process is as follows:
1. Extract Crush the dried rhizomes of Coptis chinensis and perform reflux extraction or percolation extraction using acidic aqueous solution (such as 0.5-1% sulfuric acid or hydrochloric acid) or alcohol solvents (such as methanol, ethanol). Acidic conditions help dissolve alkaloids from plant tissues and form salts.
2. purification After concentrating the extract, adjust the pH to alkaline with alkali (such as ammonia water, lime water) to allow the alkaloids to precipitate freely. The precipitate is collected by filtration to obtain the crude total alkaloids.
3. separation The total alkaloids mainly include berberine, berberine, palmatine, and jatrorrhizine. Due to the similar structures of these alkaloids, separation is difficult. Common separation methods include:
* Column chromatography method Separate using silica gel column chromatography, alumina column chromatography, or high-performance liquid chromatography (HPLC). By gradient elution using solvent systems such as chloroform methanol ammonia at different ratios, berberine can be gradually separated.
* Preparative thin layer chromatography Suitable for rapid separation of small samples.
* High Speed Counter Current Chromatography (HSCCC)A highly efficient liquid-liquid distribution chromatography technique, particularly suitable for separating structurally similar natural products, has been successfully applied in the separation and purification of coptisine in recent years.
4. salt formation The separated free base of berberine can react with sulfuric acid to produce berberine sulfate. High purity crystals of berberine sulfate can be obtained through steps such as recrystallization.
Modern extraction techniques, such as supercritical fluid extraction (SFE), microwave-assisted extraction (MAE), and ultrasound assisted extraction (UAE), have also been studied to improve the extraction efficiency and purity of berberine. These methods usually have the advantages of short extraction time, low solvent dosage, and environmental friendliness, but the cost is relatively high. Overall, establishing an efficient, environmentally friendly, and industrializable extraction and purification process for berberine sulfate is the foundation for its subsequent research and application.
Pharmacological activity research
The pharmacological activity research of berberine sulfate covers a wide range of fields, from traditional antibacterial effects to modern immune regulatory functions.
1. Antibacterial activity
As one of the main components of Huanglian, berberine sulfate inherits the broad-spectrum antibacterial properties of Huanglian. Research has shown that it exhibits inhibitory effects on various Gram positive and Gram negative bacteria. Its antibacterial mechanism may involve multiple targets, including inhibition of bacterial DNA gyrases (GyrA, GyrB), topoisomerases IV (ParC, ParE), cell division protein FtsZ, fatty acid synthase FabI, dihydrofolate reductase DHFR, as well as affecting bacterial cell wall synthesis (such as PBP2a, encoded by MecA) and fungal cell membrane ergosterol synthesis (such as Erg11/CYP51). This multi-target mode of action makes it difficult for bacteria to develop resistance, which is the advantage of natural antibiotics.
However, it should be noted that the antibacterial activity of berberine sulfate is usually weaker than berberine. This may be related to differences in cell membrane penetration ability or target binding affinity caused by structural differences. However, its activity against methicillin-resistant Staphylococcus aureus (MRSA) and other drug-resistant strains still makes it one of the candidate molecules for developing new antibiotics.
2. IDO inhibitory activity and immune regulation
The most notable pharmacological activity of berberine sulfate is its role as an IDO inhibitor. IDO is a heme containing enzyme that catalyzes the breakdown and metabolism of tryptophan along the kynurenine pathway. In the tumor microenvironment, overexpression of IDO leads to local depletion of tryptophan and accumulation of metabolites such as kynurenine, thereby inhibiting the function of effector T cells and promoting the differentiation of regulatory T cells (Tregs), forming an immunosuppressive state and helping tumor cells evade immune surveillance.
Coptidine sulfate has been identified as an effective, non competitive IDO inhibitor with a Ki value of 5.8 μ M and an IC50 value of 6.3 μ M. Non competitive inhibition means that it does not compete with tryptophan for the active center of IDO, but instead binds to other sites of the enzyme, inhibiting enzyme activity through allosteric regulation or interference with the function of cofactors such as heme. This mechanism enables it to maintain a stable inhibitory effect even when the concentration of tryptophan changes. By inhibiting IDO activity, berberine sulfate can reverse immune suppression in the tumor microenvironment, restore T cell proliferation and function, and enhance the body's anti-tumor immune response.
3. Other pharmacological activities
In addition to antibacterial and IDO inhibitory activities, berberine sulfate also exhibits various other pharmacological effects:
* anti-inflammatory effect By inhibiting inflammatory signaling pathways such as NF - κ B, the production of pro-inflammatory cytokines such as TNF - α and IL-6 is reduced.
* Antioxidant effect Its isoquinoline structure endows it with certain free radical scavenging ability.
* Antiviral effect Some studies suggest that it has inhibitory effects on certain viruses, such as influenza virus.
* Hypoglycemic and lipid-lowering effects Similar to other alkaloids in Huanglian, it may improve metabolic disorders through pathways such as AMPK.
Mechanism of action and molecular targets
The pharmacological activity of berberine sulfate originates from its interactions with various biomolecules. Its mechanism of action can be analyzed in depth from the following aspects.
1. Inhibition mechanism of IDO
As a non competitive IDO inhibitor, the mechanism of action of berberine sulfate is completely different from that of competitive inhibitors (such as 1-methyltryptophan, 1-MT). Research has shown that berberine sulfate may induce conformational changes in the IDO protein by binding to specific regions, thereby affecting its catalytic activity. Specifically, it may interfere with the binding of IDO to heme cofactors, or hinder electron transfer processes, ultimately inhibiting the oxidative cleavage of tryptophan. The advantage of this non competitive mechanism is that it can maintain effective inhibitory effects even when the concentration of tryptophan increases in the tumor microenvironment. Molecular docking and dynamic simulation studies are revealing their precise binding sites and modes of action, providing important clues for structure based drug design.
2. Multi target mechanism of antibacterial activity
The antibacterial effect of berberine sulfate is not a single target, but acts on multiple key life processes of bacteria:
* Inhibit DNA replication By inhibiting DNA gyrase (GyrA/GyrB) and topoisomerase IV (ParC/ParE), it hinders the supercoiling and melting of bacterial DNA, thereby inhibiting DNA replication and transcription.
* Inhibit cell division Binding to FtsZ protein interferes with the formation of the Z loop, thereby inhibiting bacterial cell division.
* Inhibit fatty acid synthesis Inhibit FabI (enynyl ACP reductase) and block the essential metabolic pathway of bacterial fatty acid synthesis.
* Inhibit folate synthesis Inhibiting dihydrofolate reductase (DHFR), interfering with folate metabolism, and subsequently affecting nucleic acid synthesis.
* Affects cell wall and cell membrane Inhibition of PBP2a, a MecA gene product of MRSA, can restore sensitivity to β - lactam antibiotics. Inhibition of fungal ERG11 interferes with ergosterol synthesis and damages cell membrane integrity.
This multi-target mode of action is a major characteristic of natural products and an important reason why they are less likely to develop drug resistance.
3. Interactions with other targets
In addition to IDO and antibacterial targets, berberine sulfate may also interact with other signaling pathway proteins to exert anti-inflammatory and anti-tumor effects. For example, it may downregulate the expression of inflammation related enzymes such as COX-2 and iNOS by inhibiting the activation of NF - κ B. In addition, its activation of AMPK may mediate its effect on improving glucose and lipid metabolism. These diverse target interactions together form a complex pharmacological network of berberine sulfate.
Evaluation of drug properties and pharmacokinetics
To promote the clinical application of berberine sulfate from laboratory research, it is necessary to rigorously evaluate its pharmacological properties. Its physicochemical properties and preliminary pharmacokinetic characteristics provide important references.
1. Analysis of pharmacological parameters
- Molecular weight and LogP The molecular weight of 320.3 Da conforms to the "Five Rules for Drug Types" (<500 Da). LogP is -0.1756, indicating its strong hydrophilicity, which may affect its oral absorption and cell membrane penetration. However, its high BBB penetration suggests the possibility of an active transport mechanism, partially compensating for the shortcomings of passive diffusion.
- Water solubility and TPSA Low water solubility (0.1706 mg/mL) may limit its oral bioavailability. TPSA (40.8 Å ²) is relatively small, which is conducive to membrane penetration, but the high polarity brought by the quaternary ammonium salt structure is still the main obstacle to its absorption.
- safety The negative inhibition of hERG is a significant advantage, reducing the risk of cardiac toxicity. However, the Ames test results (2.4) suggest that it may have genetic toxicity, which is a major hidden danger in its drug development. Further in vivo genetic toxicity tests (such as micronucleus test, comet assay) are needed to confirm and evaluate the risk. If genetic toxicity is confirmed, it will seriously hinder its development as a long-term oral medication, but it may be avoided through structural modifications or changes in the route of administration (such as local administration, injection).
2. Pharmacokinetic characteristics
At present, there is relatively limited specialized research on the pharmacokinetics of berberine sulfate, but data on berberine and its analogues (such as berberine) can be used for inference:
* absorb Poor oral absorption is a common problem with quaternary ammonium alkaloids. The oral bioavailability of berberine is extremely low (<5%), and berberine is expected to face the same challenge. Its absorption may mainly occur in the intestine and be limited by efflux transporters such as P-glycoprotein (P-gp).
* distribution Despite poor oral absorption, berberine sulfate has been evaluated as having high BBB penetration, suggesting that it may enter the central nervous system through carrier mediated transport. This provides the possibility for its treatment of brain diseases such as glioblastoma. Its distribution volume may be relatively large.
* Metabolism The main metabolic pathways may include demethylation, glucuronic acid binding, and sulfate binding in the liver and intestine. CYP450 enzymes may be involved in its oxidative metabolism.
* excretion Mainly excreted in the form of its original form or metabolic products through bile and urine.
3. Strategies for improving drug properties
Given its poor oral absorption and potential genetic toxicity, strategies to improve the pharmacological properties of berberine sulfate include:
* Structural modification On the premise of retaining IDO inhibitory activity, modify the quaternary ammonium nitrogen atom or aromatic ring to reduce polarity, improve oral absorption, and eliminate genetic toxicity. For example, preparing prodrugs or designing non quaternized analogues.
* Development of new dosage forms Using nanotechnology (such as liposomes, polymer nanoparticles, solid lipid nanoparticles) or phospholipid complex technology to improve their oral bioavailability. Develop injections, transdermal patches, or lung inhaled formulations to bypass oral absorption barriers.
* combination therapy Combined with P-gp inhibitors to increase their intracellular concentration. In antibacterial applications, it is used in combination with β - lactam antibiotics to overcome MRSA resistance.
Clinical application prospects and prospects
Based on its unique pharmacological activity, berberine sulfate has shown promising clinical application prospects in the following fields.
1. Tumor immunotherapy
The most direct application prospect of berberine sulfate as an IDO inhibitor is as an adjuvant drug for tumor immunotherapy. IDO inhibitors are currently a research hotspot in cancer immunotherapy, aimed at relieving immune suppression in the tumor microenvironment and enhancing the efficacy of immune checkpoint inhibitors (such as PD-1/PD-L1 antibodies). Compared to competitive IDO inhibitors in clinical trials such as Epacadostat, the non competitive inhibitory mechanism of berberine sulfate may provide different therapeutic advantages, such as more stable effects when tryptophan levels fluctuate. Future research should focus on:
* Validation of in vivo anti-tumor activity: In a variety of mouse tumor models (such as melanoma, breast cancer, colon cancer), the anti-tumor effect was evaluated individually or jointly with PD-1 antibody.
* Combined application with chemotherapy or radiotherapy Explore its synergistic effect with conventional treatment methods.
* safety assessment Due to its potential genetic toxicity, rigorous long-term toxicity studies are required, and low toxicity structural analogues should be explored.
2. Anti infection treatment
Faced with the increasingly severe problem of bacterial resistance, the multi-target antibacterial mechanism of berberine sulfate makes it a candidate for developing new antibacterial drugs. Especially its activity against MRSA and its potential to reverse beta lactam resistance have important clinical value. Future research directions include:
* Optimize antibacterial activity By structural modification, its antibacterial efficacy against specific drug-resistant bacteria such as MRSA and carbapenem resistant Escherichia coli can be improved.
* Develop local medications Due to poor oral absorption, priority can be given to developing topical formulations (such as ointments, eye drops) for skin infections, oral infections, or eye infections.
* Antifungal applications Its inhibitory effect on ERG11 suggests its potential in the treatment of fungal infections such as Candida.
3. Diseases of the central nervous system
The high BBB penetration of berberine sulfate opens the door for its application in central nervous system diseases. IDO plays an important role in neuroinflammation, and its overactivation is associated with diseases such as Alzheimer's disease, Parkinson's disease, depression, and multiple sclerosis. Inhibiting central IDO activity may alleviate neuroinflammation and improve cognitive function. Therefore, berberine sulfate is expected to be developed as a candidate drug for the treatment of neurodegenerative and psychiatric disorders. However, this requires first addressing the issue of low oral bioavailability and ensuring that its concentration in the central nervous system is sufficient to produce therapeutic effects without neurotoxicity.
Conclusion
Sulfate berberine, a natural alkaloid derived from the traditional Chinese medicine Huanglian, is undergoing a transformation from a traditional antibacterial drug to a modern immunomodulatory agent. The discovery of it as a non competitive IDO inhibitor has given it a new scientific connotation and clinical development value. This article systematically reviews its chemical structure, plant origin, pharmacological activity, mechanism of action, and medicinal characteristics.
Although berberine sulfate has shown remarkable potential in antibacterial and immune regulation, its pharmacological challenges cannot be ignored, especially in terms of poor oral absorption and potential genetic toxicity. Future research needs to deepen the elucidation of its mechanism of action, especially the precise structural basis of IDO inhibition, while vigorously conducting innovative research in medicinal chemistry and pharmacy, overcoming these obstacles through structural modification and development of new dosage forms. We have reason to believe that with the continuous deepening of research, berberine sulfate or its derivatives have the potential to transform from laboratory "potential stocks" to clinical "new weapons" in fields such as tumor immunotherapy, anti drug resistant bacterial infections, and central nervous system disease treatment, making contributions to human health. The in-depth study of such natural products once again confirms the enormous potential of combining traditional medical wisdom with modern pharmaceutical science.
